Clinical trial
Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain: a Randomized, Double-blind, Placebo-controlled Trial.
NCT05117034 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain: a Randomized, Double-blind, Placebo-controlled Trial.
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 16, 2022
- Completion date
- May 1, 2025
- Enrollment
- 115 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, anesthesia, pain, postoperative